US2008045707A1PendingUtilityA1
Processes for the preparation of linezolid intermediate
Assignee: TEVA PHARMACEUTICALS USA INC FPriority: Feb 24, 2005Filed: Oct 23, 2007Published: Feb 21, 2008
Est. expiryFeb 24, 2025(expired)· nominal 20-yr term from priority
A61K 31/5377C07D 263/20C07D 413/14C07D 413/10A61P 31/14
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides improved methods of converting R—N-(4-morpholiyl-3-fluorophenyl)-2-oxo-5-oxazolidinyl-methyl azide (III) to the intermediate S—N-(4-morpholinyl-3-fluorophenyl)-2-oxo-5-oxazolidinyl-methyl amine (II) that involve the production of fewer by-products than previous methods. The amine (II) may then be converted into linezolid (I) of high chemical purity with respect to the inactive R-enantiomer and bis-linezolid (IV), and is in high yield, without the need for tedious, complicated purification steps, such as chromatography.
Claims
exact text as granted — not AI-modified1 . A process for preparation of S—N-(4-morpholinyl-3-fluorophenyl)-2-oxo-5-oxazolidinyl-methyl amine (II) from R—N-(4-morpholinyl-3-fluorophenyl)-2-oxo-5-oxazolidinyl-methyl azide (III) by catalytic hydrogenation comprising: combining R—N-(4-morpholinyl-3-fluorophenyl)-2-oxo-5-oxazolidinyl-methyl azide (III) and a linear or branched-chain aliphatic C 1 to C 8 alcohol or a biphasic solvent system to obtain a reaction mixture; and reducing the said azide (III) using a reducing agent selected from the group of formic acid and salts thereof to obtain S—N-(4-morpholinyl-3-fluorophenyl)-2-oxo-5-oxazolidinyl-methyl amine (II).
2 . The process of claim 1 , wherein the alcohol is ethanol or butanol.
3 . The process of claim 1 , wherein the amount of alcohol is about 10 volumes to about 25 volumes relative to the said azide.
4 . The process of claim 1 , wherein the amount of alcohol is about 15 volumes (g/mL) relative the said azide.
5 . The process of claim 1 , wherein the aqueous solvent of the biphasic solvent is water.
6 . The process of claim 1 , wherein the organic solvent of the biphasic solvent is ethylacetate.
7 . The process of claim 1 , wherein the ratio of organic solvent:water of the biphasic solvent is from about 0.1:1 to about 10:1
8 . The process of claim 7 , wherein the ratio of organic solvent:water of the biphasic solvent is about 1:1.
9 . The process of claim 1 , wherein the process comprises a phase transfer agent and the phase transfer agent is tetrabutylammonium bromide (TBAB) or Aliquot 336.
10 . The process of claim 1 , wherein the reducing agent is ammonium formate.
11 . The process of claim 1 , wherein reduction conducted in the presence of zinc or a noble metal catalyst on an inert support such as carbon, activated carbon, alumina or zinc.
12 . The process in claim 11 , wherein the noble metal catalyst is palladium on carbon (“Pd/C”).
13 . The process in claim 11 , wherein the noble metal catalyst is in an amount of about 2-20% compared to the azide.
14 . The process in claim 11 , wherein the zinc is in an amount of about 1 to 2 equivalents, relative to the azide.
15 . The process in claim 11 , wherein the reduction is carried out to completion as judged by using periodic TLC or HPLC analysis.
16 . The process in claim 1 further comprising converting the said amine (II) into linezolid.
17 . The process of claim 16 , wherein the linezolid (I) produced comprises less than about 3.2% of bis-linezolid (IV).
18 . The process of claim 17 , wherein the linezolid (I) produced comprises less than about 1% of bis-linezolid (IV).
19 . The process of claim 18 , wherein the linezolid (I) produced comprises less than about 0.1% of bis-linezolid (IV).
20 . The process of claim 16 , wherein the linezolid (I) produced comprises less than about 0.05% of bis-linezolid (IV).
21 . The process of claim 16 , wherein pure linezolid (I) is produced having a purity of more than about 95% with respect to reaction by-product impurities.
22 . The process of claim 16 , wherein pure linezolid (I) is produced having a purity of more than about 98% with respect to reaction by-product impurities.
23 . The process of claim 22 , wherein pure linezolid (I) is produced having a purity of more than about 99% with respect to reaction by-product impurities.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.